China slowdown, El Nino cloud future for Thai durian exports
BANGKOK -- Thai durian exports to China have surged since a high-speed rail link opened between neighboring Laos and the world's No. 2 economy, cutting delivery times and offering a fresh delivery route for the famously pungent fruit. But an economic slowdown in China and the impact of the El Nino…#thai #laos #elnino #southeastasia
Source: Reuters: Health - September 2, 2023 Category: Consumer Health News Source Type: news

Trader Says Ethereum-Based Altcoin Could Crash by Up to 50%, Updates Outlook on Bitcoin (BTC) and Optimism (OP)
A widely followed crypto analyst says that one mid-cap altcoin could see a massive correction as whale transactions including the asset see a decline. Crypto trader Ali Martinez tells his 29,900 followers on the social media platform X that blockchain oracle provider Chainlink (LINK) could dip by…#alimartinez #bitcoinonchaindata #ethereum #eth #twitter #dailyhodl #tradersaysethereum #updatesoutlook #optimism
Source: Reuters: Health - September 1, 2023 Category: Consumer Health News Source Type: news

Chainlink Exchange Supply Plummets, Is This Bullish?
On-chain data shows the Chainlink exchange supply has observed a plummet, something that could turn out to be bullish for the asset’s price. Chainlink Supply On Exchanges Has Registered A Drawdown Recently According to data from the on-chain analytics firm Santiment, the LINK supply on exchanges…
Source: Reuters: Health - September 1, 2023 Category: Consumer Health News Source Type: news

Shiba Inu Founder Linked to CCP, Wanxiang, Vitalik Buterin
In a groundbreaking revelation, on-chain researcher BoringSleuth has unveiled a series of connections that link the enigmatic founder of Shiba Inu, known as Ryoshi, to some of the most influential figures and organizations in the crypto space. The researcher’s thread, released earlier today,…#boringsleuth #shibainu #vitalikbuterin #ccp #shib #shibainucreator #binancedev #cryptokitties #ethereum #rogerlim
Source: Reuters: Health - September 1, 2023 Category: Consumer Health News Source Type: news

UK scientists find link between proteins related to blood clots and long Covid
Biomarker discovery indicates that sufferers from brain fog and fatigue post-virus could be treated with anticoagulantsScientists have identified molecular signatures in the blood that are linked to brain fog, other cognitive problems and fatigue in patients who are diagnosed withlong Covid after catching the virus.Raised levels of two different proteins were more common in people who developed long Covid symptoms that affected their brains, the researchers found. Both are hallmarks of blood clots in the body, the likely cause of the symptoms reported.Continue reading...
Source: Guardian Unlimited Science - August 31, 2023 Category: Science Authors: Oksana Pyzik Tags: Long Covid Coronavirus Medical research UK news Health Science Source Type: news

SWIFT Embraces Crypto: Integration With Chainlink A Success?
The Society for Worldwide Interbank Financial Telecommunications (SWIFT) announced a success with its integration with Chainlink (LINK). The international entity has been experimenting with blockchain technology, both private and public networks, and finally revealed the progress of its efforts.…#swift #bnymellon #citieuroclear #lloydsbankinggroup #sixdigitalexchange #ethereum #ccip #cover #unsplash #tradingview
Source: Reuters: Health - August 31, 2023 Category: Consumer Health News Source Type: news

Study Finds Link Between Asbestos Exposure and Autoimmune Conditions
Asbestos is widely known as an occupational hazard, but emerging evidence suggests that prolonged exposure to environmental asbestos could lead to severe autoimmune conditions, according to a study by Montana State University researchers. Microbiology and immunology research associate Dr. Jean Pfau and a team of researchers discovered the connection to a specific type of asbestos found near the once badly contaminated town of Libby, Montana, and a novel autoimmune disease. The autoimmune condition is associated with collagen thickening of the serum-producing membranes surrounding the lungs. Pfau, chairperson for the ...
Source: Asbestos and Mesothelioma News - August 31, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Clinical Trials/Research/Emerging Treatments Source Type: news

Threat of harm beliefs mediate the link between binegativity and sexual assault-related PTSD among cisgender bisexual women - Salim SR, Eshelman LR, McConnell AA, LaPlena NM, Messman TL.
OBJECTIVE: Bisexual women experience disparities in sexual assault and in posttraumatic stress disorder (PTSD) compared to heterosexual and lesbian women. Bisexual women also experience unique stigma due to their bisexual identity (i.e., binegativity), whi...
Source: SafetyLit - August 31, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Empirically derived patterns of adverse childhood experiences and associations with prenatal social networks - Napier TR, Howell KH, Scheid CR, Miller-Graff LE.
This study explored classes of ACEs in association with fami...
Source: SafetyLit - August 31, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Reminder: Invitation to Roche ’s Pharma Day 2023
 The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 11 September 2023, starting at 10:00 BST and finishing at 14:30 BST with a reception.The Roche Pharma Day will address the following topics: Group / Pharma strategyCommercial growth driversPipeline updatesOncology, Hematology, Neuroscience, Ophthalmology, Immunology Presenters include:ThomasSchinecker, CEO Roche GroupTeresa Graham, CEO Roche PharmaceuticalsLevi Garraway, Chief Medical Officer and Head of Global Product DevelopmentCharlie Fuchs, Senior Vice President and Global Head of Oncology an...
Source: Roche Investor Update - August 31, 2023 Category: Pharmaceuticals Source Type: news

Chainlink Starterpack (The Oracle Of Crypto)
Everyone seems to be bullish on Chainlink and you may be wondering if you should add its native token, LINK, to your portfolio.
Source: Reuters: Health - August 31, 2023 Category: Consumer Health News Source Type: news

‘Beer goggles’ study finds alcohol does not make people seem better looking
US research casts doubt on anecdotal evidence, but suggests drinking may give you ‘courage’ to approach attractive peopleIf you thought beauty was in the eye of the beer holder, think again. Scientists have poured cold water – or rather, vodka – on the existence of “beer goggles”: the idea that alcohol makes other people appear better looking. However, it may arm you with the “liquid courage” to approach attractive people, the research suggests.The term “beer goggles” is said to have been coined by male North American university students in the 1980s. Yet despite anecdotal evidence for the phenomenon, t...
Source: Guardian Unlimited Science - August 30, 2023 Category: Science Authors: Linda Geddes Science correspondent Tags: Alcohol Psychology Science Research Society US news Source Type: news

Kenvue Fits Right In With Other Dividend Aristocrats
The company that sells iconic brands such as Tylenol is a spinout from J&J. For income seekers, that link is vital for the next two years.#tylenol
Source: Reuters: Health - August 30, 2023 Category: Consumer Health News Source Type: news

No Link Between Most Cancers and Depression/Anxiety: Study No Link Between Most Cancers and Depression/Anxiety: Study
The findings challenge a common theory that depression and anxiety increase cancer risk and should"change current thinking," they argue.MDedge News
Source: Medscape Medical News Headlines - August 29, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Roche ’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes
Tecentriq subcutaneous (SC) is now approved in Great Britain for all indications of intravenousTecentriq, including certain types of lung, bladder, breast and liver cancer, offering a faster, more convenient option to receive treatmentAdministered under the skin within approx. seven minutes,Tecentriq SC saves time for patients and helps conserve resources in healthcare systems1Evaluations by the FDA, EMA and other health authorities globally are ongoingBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Tecentriq ® SC (atezolizumab) has been approved by the Medicines and Healthcare products Reg...
Source: Roche Investor Update - August 29, 2023 Category: Pharmaceuticals Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20